[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ATE344050T1 - Verwendung von tcf-ii zur behandlung von durch krebs verursachtem gewichtsverlust, anaemie und tnf-erhöhung - Google Patents

Verwendung von tcf-ii zur behandlung von durch krebs verursachtem gewichtsverlust, anaemie und tnf-erhöhung

Info

Publication number
ATE344050T1
ATE344050T1 AT98907159T AT98907159T ATE344050T1 AT E344050 T1 ATE344050 T1 AT E344050T1 AT 98907159 T AT98907159 T AT 98907159T AT 98907159 T AT98907159 T AT 98907159T AT E344050 T1 ATE344050 T1 AT E344050T1
Authority
AT
Austria
Prior art keywords
tcf
cancer
anaemia
tnf
elevation
Prior art date
Application number
AT98907159T
Other languages
English (en)
Inventor
Masamichi Kojiro
Hirohisa Yano
Akihiro Iemura
Original Assignee
Daiichi Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Seiyaku Co filed Critical Daiichi Seiyaku Co
Application granted granted Critical
Publication of ATE344050T1 publication Critical patent/ATE344050T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18Growth factors; Growth regulators
    • A61K38/1833Hepatocyte growth factor; Scatter factor; Tumor cytotoxic factor II
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Nutrition Science (AREA)
  • Obesity (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT98907159T 1997-03-14 1998-03-11 Verwendung von tcf-ii zur behandlung von durch krebs verursachtem gewichtsverlust, anaemie und tnf-erhöhung ATE344050T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP8216297 1997-03-14

Publications (1)

Publication Number Publication Date
ATE344050T1 true ATE344050T1 (de) 2006-11-15

Family

ID=13766743

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98907159T ATE344050T1 (de) 1997-03-14 1998-03-11 Verwendung von tcf-ii zur behandlung von durch krebs verursachtem gewichtsverlust, anaemie und tnf-erhöhung

Country Status (10)

Country Link
US (4) US20020041863A1 (de)
EP (1) EP0950416B1 (de)
AT (1) ATE344050T1 (de)
AU (1) AU734766B2 (de)
CA (1) CA2253629A1 (de)
DE (1) DE69836315T2 (de)
DK (1) DK0950416T3 (de)
ES (1) ES2274567T3 (de)
WO (1) WO1998041230A1 (de)
ZA (1) ZA982068B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4006058B2 (ja) 1997-03-11 2007-11-14 第一三共株式会社 多臓器不全予防及び/又は治療剤
ZA982068B (en) 1997-03-14 1998-09-16 Snow Brand Milk Products Co Ltd Agent for preventing and/or treating cachexia
JPH1129493A (ja) * 1997-07-14 1999-02-02 Snow Brand Milk Prod Co Ltd 放射線障害予防及び/又は治療剤
CA2677452A1 (en) * 2007-02-14 2008-08-21 Karolinska Innovations Ab Compositions for increasing body weight, use and methods
CA2699854A1 (en) * 2007-09-17 2009-03-26 Bioneris Ab Use of compounds comprising phosphorous for the treatment of cachexia
EP2221043A1 (de) 2009-02-21 2010-08-25 Bayer MaterialScience AG Haarfestiger-Zusammensetzung
TW201333870A (zh) 2011-12-21 2013-08-16 艾登工具股份有限公司 決定病人胰島素療法的系統及方法
US20220047643A1 (en) * 2019-01-17 2022-02-17 Figene, Llc Fibroblasts and microvesicles thereof for reduction of toxicity associated with cancer immunotherapy

Family Cites Families (74)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US604185A (en) * 1898-05-17 Submarine boat
US498680A (en) * 1893-05-30 Boat for transporting railroad-cars
US539590A (en) * 1895-05-21 passoni
US604184A (en) * 1898-05-17 Oil-can
US462277A (en) * 1891-11-03 Or reducing mill
US587311A (en) * 1897-08-03 Regulating admission of currents to motors
US950416A (en) * 1910-02-22 Albert Sutton Wheel-tire.
US653211A (en) * 1900-04-03 1900-07-10 John H Calkins Box for spool goods.
US757994A (en) * 1903-04-09 1904-04-19 Oliver Chilled Plow Works Sulky lister-plow.
US914829A (en) * 1908-08-26 1909-03-09 Albert O Hanson Can-opener.
US2116192A (en) * 1936-03-26 1938-05-03 Draminsky Per Elastic coupling
US2100720A (en) * 1937-01-11 1937-11-30 Shaw Walker Co Letter tray
US3904753A (en) 1970-02-20 1975-09-09 Research Corp Clinically active bovine growth hormone fraction
US4076701A (en) 1975-07-29 1978-02-28 Immunology Research Foundation, Inc. Tumor complement fraction recovery method and product
US4490549A (en) 1977-04-19 1984-12-25 The Upjohn Company Enlarged-hetero-ring prostacyclin analogs
US4481137A (en) 1982-02-26 1984-11-06 Mochida Pharmaceutical Co., Ltd. Glycoproteins and processes for their production
JPS60112718A (ja) 1983-11-21 1985-06-19 Kyorin Pharmaceut Co Ltd 抗腫瘍作用を示す蛋白性物質及びその製造方法
US4650674A (en) 1984-07-05 1987-03-17 Genentech, Inc. Synergistic cytotoxic composition
US4870163A (en) 1985-08-29 1989-09-26 New York Blood Center, Inc. Preparation of pure human tumor necrosis factor and hybridomas producing monoclonal antibodies to human tumor necrosis factor
US5326716A (en) * 1986-02-11 1994-07-05 Max Planck-Gesellschaft Zur Foerderung Der Wissenschaften E.V. Liquid phase epitaxial process for producing three-dimensional semiconductor structures by liquid phase expitaxy
US4822605A (en) 1986-02-18 1989-04-18 Exovir, Inc. Compositions and methods employing the same for the treatment of viral and cancerous skin lesions and the like
JPS6429951A (en) 1987-07-24 1989-01-31 Hitachi Ltd Storage system
JPS6468400A (en) 1987-09-09 1989-03-14 Sapporo Breweries Human tumor cytotoxic factor htcf, production thereof and antitumor agent comprising said factor as active ingredient
KR890009412A (ko) 1987-12-22 1989-08-01 마쓰시따 렌조오 종양 세포 억제 인자
JPH0296598A (ja) 1988-10-03 1990-04-09 Sapporo Breweries Ltd リンフォカイン活性化キラー細胞誘導抑制因子laksf,その製造法およびそれを有効成分とする免疫抑制剤
NZ232813A (en) 1989-03-10 1992-08-26 Snow Brand Milk Products Co Ltd Human fibroblast glycoprotein, cell differentiation, blood vessel endothelial cell growth factor, cellular immunology inforcing factor of 78 or 74 thousand daltons plus or minus two thousand daltons
US5035887A (en) 1989-09-07 1991-07-30 Institute Of Moelcular Biology, Inc. Wound healing composition of IL-1 and PDGF or IGF-1
US5362716A (en) 1989-12-27 1994-11-08 The United States Of America As Represented By The Department Of Health And Human Services Methods for stimulating hematopoietic progenitors using hepatocyte growth factor and lymphokines
US5648273A (en) 1989-12-27 1997-07-15 The United States Of America, As Represented By The Department Of Health And Human Services Hepatic growth factor receptor is the MET proto-oncogene
JP2784455B2 (ja) 1990-05-09 1998-08-06 敏一 中村 肝硬変治療剤
DE69133492T2 (de) 1990-06-11 2006-08-10 Nakamura, Toshikazu Rekombinanter menschlicher Hepatozytwachstumsfaktor und Verfahren zu seiner Herstellung
JP2750372B2 (ja) 1990-06-19 1998-05-13 敏一 中村 賢疾患治療剤
ATE178354T1 (de) 1990-07-13 1999-04-15 Snow Brand Milk Products Co Ltd Plasmid das für die aminosäuresequenz von tcf-ii kodierende dns enthalt, transformierte zelle und produktion einer physiologisch aktiven substanz mit ihrer verwendung
US5821223A (en) 1990-09-14 1998-10-13 The United States Of America As Represented By The Department Of Health And Human Services Method of stimulating cell growth with a novel broad spectrum human lung fibroblast-derived mitogen
RU2120447C1 (ru) 1991-02-08 1998-10-20 Санкио Компани Лимитед ПРОИЗВОДНЫЕ β АМИНО α ГИДРОКСИКАРБОНОВЫХ КИСЛОТ ИЛИ ИХ ФАРМАЦЕВТИЧЕСКИ ПРИЕМЛЕМЫХ СОЛЕЙ ИЛИ ЭФИРОВ, ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ
JPH0597A (ja) 1991-06-21 1993-01-08 Snow Brand Milk Prod Co Ltd 新規抗tcf−iiモノクローナル抗体及びそれを用いるtcf−iiの測定方法
JP3394982B2 (ja) 1991-11-07 2003-04-07 敏一 中村 ガン療法用副作用防止剤
WO1993013066A1 (en) 1991-12-20 1993-07-08 Syntex (U.S.A.) Inc. Cyclic amides of 3-amino-2-hydroxy-carboxylic acids as hiv-protease inhibitors
JP3123617B2 (ja) 1992-03-04 2001-01-15 雪印乳業株式会社 シアル酸結合を有する化合物の製造法
NO178729C (no) 1992-03-31 1996-05-22 Daiichi Seiyaku Co Terapeutisk aktive sukkerderivater
US5315000A (en) 1992-05-14 1994-05-24 Children's Hospital Medical Center Gene encoding for a L5/3 growth factor and its CDNA
DE69332221T2 (de) 1992-05-18 2003-04-17 Genentech, Inc. Hepatozytwachstumfaktor Variante
JPH0656692A (ja) 1992-08-10 1994-03-01 Snow Brand Milk Prod Co Ltd Tcf−iiを有効成分とする創傷治療剤
ES2110057T3 (es) 1992-07-16 1998-02-01 Snow Brand Milk Products Co Ltd Composicion medicinal que contiene tcf-ii.
JP3619526B2 (ja) 1992-07-16 2005-02-09 第一製薬株式会社 Tcf−iiを有効成分とする肝臓疾患治療剤
JP3380573B2 (ja) 1992-07-16 2003-02-24 第一製薬株式会社 Tcf−iiを有効成分とする蛋白合成促進剤
DE69330960T2 (de) 1992-07-16 2002-04-11 Snow Brand Milk Products Co., Ltd. Normalisierer der blutkoagulation enthaltend tcf-ii als aktiven bestandteil
JP3697460B2 (ja) 1992-07-17 2005-09-21 敏一 中村 Hgf含有製剤
AU662434B2 (en) 1992-08-07 1995-08-31 Sankyo Company Limited Peptides capable of inhibiting the activity of HIV protease, their preparation and their use
JP3402476B2 (ja) 1992-08-24 2003-05-06 生化学工業株式会社 リポ多糖結合性タンパク質及びその製造法
WO1994006456A1 (en) 1992-09-16 1994-03-31 Genentech, Inc. Protection against liver damage by hgf
US5703047A (en) 1992-09-21 1997-12-30 Board Of Regents, The University Of Texas System Methods and treatments for corneal healing with growth factors
US5589451A (en) 1992-09-21 1996-12-31 Board Of Regents, The University Of Texas System Methods and treaments for corneal healing with hepatocyte and keratinocyte growth factors
JPH06116299A (ja) 1992-10-02 1994-04-26 Snow Brand Milk Prod Co Ltd 特定の糖鎖構造により高い生物活性を有する遺伝子組換え型tcf
MX9308016A (es) 1992-12-22 1994-08-31 Lilly Co Eli Compuestos inhibidores de la proteasa del virus de la inmunodeficiencia humana, procedimiento para su preparacion y formulacion farmaceutica que los contiene.
US5554653A (en) 1992-12-22 1996-09-10 Eli Lilly And Company Inhibitors of HIV protease useful for the treatment of AIDS
EP0628055A1 (de) 1992-12-28 1994-12-14 Snow Brand Milk Products Co. Ltd. Modifizierter tcf
JP3552240B2 (ja) 1993-02-23 2004-08-11 第一製薬株式会社 高濃度tcf製剤
JP3962097B2 (ja) 1994-03-18 2007-08-22 敏一 中村 免疫抑制剤による副作用の軽減剤
JPH07258298A (ja) 1994-03-18 1995-10-09 Snow Brand Milk Prod Co Ltd モノクローナル抗体
US5707624A (en) 1994-06-03 1998-01-13 The Regents Of The University Of Michigan Treatment of Kaposi's sarcoma by inhibition of scatter factor
ATE248913T1 (de) 1994-12-27 2003-09-15 Daiichi Seiyaku Co Tcf mutante
NZ298141A (en) 1994-12-27 2000-12-22 Snow Brand Milk Products Co Ltd Treating lipid metabolism disorder using TCF-II
JPH08231418A (ja) 1995-02-24 1996-09-10 Mitsubishi Chem Corp 腸疾患治療剤
AU4953796A (en) 1995-03-15 1996-10-02 Sanyko Company, Limited Dipeptide compounds having ahpba structure
CA2218864A1 (en) 1995-04-21 1996-10-24 Tsutomu Yonehana Agent for preventing and/or treating ischemic diseases
JPH10194986A (ja) 1996-06-10 1998-07-28 Snow Brand Milk Prod Co Ltd 移植肝機能改善・再生促進剤
JP3887435B2 (ja) 1996-07-12 2007-02-28 第一製薬株式会社 スフェロイド形成促進剤
JPH1068400A (ja) 1996-08-28 1998-03-10 Tetsuo Taira 液体を押し出すボトルポンプ及びその方法と製造方法
JP4006058B2 (ja) 1997-03-11 2007-11-14 第一三共株式会社 多臓器不全予防及び/又は治療剤
ZA982068B (en) 1997-03-14 1998-09-16 Snow Brand Milk Products Co Ltd Agent for preventing and/or treating cachexia
JP3961064B2 (ja) 1997-03-28 2007-08-15 第一製薬株式会社 腎疾患予防及び/又は治療剤
JPH1129493A (ja) 1997-07-14 1999-02-02 Snow Brand Milk Prod Co Ltd 放射線障害予防及び/又は治療剤
JPH11269091A (ja) 1998-03-19 1999-10-05 Snow Brand Milk Prod Co Ltd 敗血症予防及び/又は治療剤

Also Published As

Publication number Publication date
DK0950416T3 (da) 2007-02-26
DE69836315T2 (de) 2007-05-31
US20030082134A1 (en) 2003-05-01
EP0950416B1 (de) 2006-11-02
US7115568B2 (en) 2006-10-03
EP0950416A1 (de) 1999-10-20
AU6309398A (en) 1998-10-12
DE69836315D1 (de) 2006-12-14
WO1998041230A1 (fr) 1998-09-24
EP0950416A4 (de) 2004-06-16
CA2253629A1 (en) 1998-09-24
ZA982068B (en) 1998-09-16
AU734766B2 (en) 2001-06-21
US20020041863A1 (en) 2002-04-11
ES2274567T3 (es) 2007-05-16
US7138372B2 (en) 2006-11-21
US20060193827A1 (en) 2006-08-31
US20030236191A1 (en) 2003-12-25

Similar Documents

Publication Publication Date Title
ATE499934T1 (de) Verwendung von (3.2.0) heterocyclischen verbindungen und ihren analoga zur behandlung von krebs
DE69108048D1 (de) Derivate von hydroxaminsäure und von n-hydroxyharnstoff sowie ihre verwendung.
DK0871439T3 (da) Substituerede (aryl, heteroaryl, arylmethyl eller heteroarylmethyl) hydroxamsyreforbindelser
EA200000723A1 (ru) Производные 2-(пурин-9-ил)-тетрагидрофуран-3,4-диола
ATE317262T1 (de) Verwendung von tetracyclinderivaten zur steigerung der interleukin-10 produktion
DE69627467D1 (de) Verwendung von zusammensetzungen mit benzoylperoxyd, glycolsäure und zink zur behandlung von dermatologischen krankheiten
ID21526A (id) 4-hidroksiquinolin-3-karboksamida dan hidrazida sebagai bahan anti-virus
WO2003105757A3 (en) METHODS AND COMPOSITIONS FOR MEDIA-DEPENDENT BINDING OF A TARGET AGENT TO A TARGET
ATE238792T1 (de) Verwendung von makroliden zur behandlung von glaukom
DE3484395D1 (de) Laser zur medizinischen behandlung kranker bereiche organischen gewebes.
DE69930271T8 (de) Medizinische zusammensetzungen zur behandlung von augenerkrankungen
DE69607615D1 (de) Neuartige metalloprotease-inhibitoren und diese enthaltende pharmazeutische zusammensetzungen
ATE344050T1 (de) Verwendung von tcf-ii zur behandlung von durch krebs verursachtem gewichtsverlust, anaemie und tnf-erhöhung
ES2090081T3 (es) Derivados de indolocarbazol, procedimientos para su obtencion y su empleo.
BR0213417A (pt) Compostos e composições de tetraciclicazaindóis e indolinas tendo atividade de 5-ht e seus usos
EE9900450A (et) Tetrahüdropüridoühendid, neid sisaldav ravim ja nende kasutamine
DE59710517D1 (de) Adamantanaminenderivate zur bekämpfung von viren der familie bornaviridae
BR0210401A (pt) Composto, composição farmacêutica, uso de um composto e método para o tratamento de um distúrbio ou de uma doença de um corpo de animal vivo, incluindo um humano
DE60018704D1 (de) Bretyliumhaltige zusammensetzungen und kits und deren verwendung zur vorbeugung und behandlung cardiovaskulärer erkrankungen
ATE517626T1 (de) Aminosubstituierte sulphonanilide und ihre derivate zur behandlung von proliferativen erkrankungen
ATE316379T1 (de) Oxyhuminsäure und ihre verwendung zur behandlung von verschiedenenen störungen
DK0821969T3 (da) Medicinsk sammensætning omfattende TCF-II
ATE185274T1 (de) Therapeutisches mittel gegen drohenden abortus
RU95110774A (ru) Олигонуклеотиды, терапевтические композиции, применение композиций
DE69103773D1 (de) Derivate von hydroxaminsäure die lipoxygenase hemmen.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0950416

Country of ref document: EP

EEIH Change in the person of patent owner
REN Ceased due to non-payment of the annual fee